The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
Illinois AI Law Could Test Emerging Federal Approach to Frontier AI
Illinois’ frontier AI audit requirements arrive as the Trump administration takes a more active approach to advanced AI risks.
4m read -
Building a Secure Foundation for AI in Federal Health
HP Federal CTO Tommy Gardner discusses how edge AI, cybersecurity and responsible adoption are shaping federal health IT modernization.
9m watch -
Trump Order Aims to Speed Veterans' Benefits Through DOW-VA Data Sharing
A new executive order directs DOW and VA to improve military records sharing and modernize IT systems to speed veterans’ access to benefits.
3m read -
Building Resilient Teams: Culture Eats Strategy for Breakfast
Jamie Holcombe shares how trust, mission clarity and employee well-being help leaders build resilient teams and sustain innovation.
24m watch
